Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Cancer Causes & Control : CCC|January 19, 2012
Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonatesTanya Agurs-Collins, Sabine Rohrmann, Catherine Sutcliffe, et al.
Molecular Cancer Therapeutics|December 4, 2013
Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycinKatrin Friedbichler, Marco H Hofmann, Monika Kroez, et al.
International Journal of Cancer|July 13, 2002
A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancerStacey A Missmer, Christopher A Haiman, David J Hunter, et al.
International Journal of Cancer|October 29, 2014
Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancerYin Cao, Katharina Nimptsch, Irene M Shui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2010
Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studiesJason B Douglas, Debra T Silverman, Stephanie J Weinstein, et al.
Breast Cancer Research : BCR|March 15, 2012
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study IIMegan S Rice, Rulla M Tamimi, James L Connolly, et al.
International Journal of Cancer|June 25, 2009
Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast diseaseXuefen Su, Graham A Colditz, Walter C Willett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonatesSabine Rohrmann, Catherine G Sutcliffe, Jessica L Bienstock, et al.
The Lancet. Oncology|June 13, 2015
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trialSil Kordes, Michael N Pollak, Aeilko H Zwinderman, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|March 15, 2006
Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3)Tiffany G Harris, Howard D Strickler, Herbert Yu, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Cancer Causes & Control : CCC|January 19, 2012
Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonatesTanya Agurs-Collins, Sabine Rohrmann, Catherine Sutcliffe, et al.
Molecular Cancer Therapeutics|December 4, 2013
Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycinKatrin Friedbichler, Marco H Hofmann, Monika Kroez, et al.
International Journal of Cancer|July 13, 2002
A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancerStacey A Missmer, Christopher A Haiman, David J Hunter, et al.
International Journal of Cancer|October 29, 2014
Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancerYin Cao, Katharina Nimptsch, Irene M Shui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 22, 2010
Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studiesJason B Douglas, Debra T Silverman, Stephanie J Weinstein, et al.
Breast Cancer Research : BCR|March 15, 2012
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study IIMegan S Rice, Rulla M Tamimi, James L Connolly, et al.
International Journal of Cancer|June 25, 2009
Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast diseaseXuefen Su, Graham A Colditz, Walter C Willett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonatesSabine Rohrmann, Catherine G Sutcliffe, Jessica L Bienstock, et al.
The Lancet. Oncology|June 13, 2015
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trialSil Kordes, Michael N Pollak, Aeilko H Zwinderman, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|March 15, 2006
Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3)Tiffany G Harris, Howard D Strickler, Herbert Yu, et al.
Pageof 18